Podcasts about Export

Joe's Premium Subscription: www.standardgrain.comGrain Markets and Other Stuff Links —Apple PodcastsSpotifyTikTokYouTubeFutures and options trading involves risk of loss and is not suitable for everyone.

If you had £500,000 to enter the US with your MedTech product, where would you spend it first?For clinician founders looking to export a medical device to the US, the size of the opportunity can make it tempting to think big from day one. But entering the US MedTech market and scaling across it are two very different decisions. In this episode, Hakeem and international growth and commercialisation consultant Craig T. Ingram explore whether you should build a US sales team, appoint a distributor, raise more capital or prove your commercial model in one defined market segment first. In this episode you'll discover:Why treating the US as one enormous MedTech market can lead to expensive commercial and export decisions.How proving your commercial model in one defined US customer segment can help you understand acquisition costs, adoption pathways and whether your product can actually make money before you scale. Why hiring a sales team, appointing a distributor or raising more capital shouldn't substitute for first understanding exactly where, how and why your medical device will sell in the US. Listen now to discover how to approach US MedTech market entry, prove your commercial model and make your export budget work harder before committing significant capital to scaling.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Michael Sobolik and  Gordon Chang examine how Chinese AI company Moonshot bypassed US export controls by "distilling" technology from Anthropic's Claude Opus model to train its own system, Kimi K3. This intellectual property theft threatens American market dominance and national security. Sobolik recommends three policy actions: imposing crushing financial sanctions on violating Chinese firms, closing export control loopholes related to remote cloud access, and banning open CCP models in the United States. He warns that American tech companies prioritizing short-term profits over security risk losing the AI race, mirroring historical patterns of Chinese piracy. (9)

Edmund Fitton-Brown critiques the term "economic D-Day," explaining that Pakistan's mediation in Iran is self-interested, driven by fears of secondary US sanctions. These sanctions have suffocated Iran's economy, reducing oil exports and sparking hyperinflation. Iraq also struggles with contradictory policies, balancing its US alliance with pro-Iranian gestures, such as securing tanker passage through the Strait of Hormuz. In the Red Sea, the Houthis demand tribute from Saudi Arabia to halt attacks on tankers and pipelines. Fitton-Brown warns that paying the Houthis only delays their long-term expansionist goals against Saudi territory and Israel. (7)

Olibris v. Blanche, No. 25-60322 (5th Cir. Aug.  13, 2026)INA § 237(a)(4)(A)(i); prohibiting the export of goods; firearms to Haiti; 18 U.S.C. § 554; cannot of noscitur a sociis Guerra Quezada, et al. v. United States, No. 25-10372 (5th Cir. Aug. 14, 2026)derivative citizenship; constructive presence; Matter of Navarrete Matter of M-M-L-J-, 29 I&N Dec. 843 (BIA 2026)number bar to motion to reopen; statutory interpretation; no equitable tolling of number bar; sua sponte Ramdial v. U.S. Att'y Gen., No. 25-10093 (11th Cir. Aug. 21, 2026)aggravated felony theft offense; INA § 101(a)(43)(G); robbery by sudden snatching in violation of Fla. Stat. § 812.131(1); without consent; de minimus taking; divisibility; elements vs means; intent to deprive Wong v. Blanche, No. 22-6185 (2d Cir. Aug. 19, 2026)definition of immigration conviction; disorderly persons theft by deception – N.J. Stat. Ann. § 2C:20-4; Apprendi; sentence; formal adjudication of guilt; Loper BrightPopPopuli!Kurzban Kurzban Tetzeli and Pratt P.A.Immigration, serious injury, and business lawyers serving clients in Florida, California, and all over the world for over 40 years.eimmigration"Immigration law software you'll love to use."get.eimmigration.com/IRPheroes.eimmigration.com.  Gonzales & Gonzales Immigration BondsP: (833) 409-9200immigrationbond.com Stafi"Remote staffing solutions for businesses of all sizes"Click me!Want to become a patron?Show the Podcast some loooovvveeeCONTACT INFORMATION:Email: kgregg@kktplaw.comFacebook: @immigrationreviewInstagram: @immigrationreviewTwitter: @immreviewAbout your hostCase notesRecent criminal-immigration article (p.18)Featured in San Diego VoyagerSupport the show

Can you help me make more podcasts? Consider supporting me on Patreon as the service is 100% funded by you: https://EVne.ws/patreon You can read all the latest news on the blog here: https://EVne.ws/blog Subscribe for free and listen to the podcast on audio platforms:➤ Apple: https://EVne.ws/apple➤ YouTube Music: https://EVne.ws/youtubemusic➤ Spotify: https://EVne.ws/spotify➤ TuneIn: https://EVne.ws/tunein➤ iHeart: https://EVne.ws/iheart CHINA'S EV EXPORT SURGE MEETS STOCK RISK https://evne.ws/nesqb BYD NAMES THIRD-GENERATION TANG https://evne.ws/n6gma BYD ADDS LONG-RANGE TAI 7 DM https://evne.ws/t1hau AITO M9 ULTIMATE OPENS PRE-SALES https://evne.ws/aief9 GEELY READIES SOLID-STATE BATTERY PILOT https://evne.ws/1sxdl NIO HANDS WUHAN SWAP ASSETS TO STATE PARTNERS https://evne.ws/8vg2h CHERY PLANS BEDFORDSHIRE R&D CENTRE https://evne.ws/bdjx6 LEAPMOTOR LAUNCHES EXTENDED-RANGE SUVS IN ARGENTINA https://evne.ws/sit5x

Die Erkenntnis über eine nicht mehr stabile Grundposition der nationalen Automobilwirtschaft speist sich aus vielen Dimensionen, die die große Klammer, den grundlegenden Sound und das mentale Echo von “Made in Germany” nach und nach verhallen lässt. In Podcast Episode #142 liefern wir eine kurze Betrachtung über das "Ende des klassischen Exportmodells" der deutschen Wirtschaft, wie die Wertschöpfung hierzulande erodiert. In der Automobilindustrie wird dies wohl am deutlichsten sichtbar. Wie fördert man ein Veränderungstempo und einen anderen Probiergeist? Hört rein!

Gas is back at the center of the energy debate. Surging demand for electricity to power new data centres, and growing fears about global energy security resulting from the conflict in the Middle East, are raising some urgent questions for the US gas industry. Consumers want to know whether the US can produce enough gas for the world without losing the price advantage that has benefited American consumers for many years? Can a new era of gas growth strengthen energy security abroad and support cutting-edge technological innovation at home, while also maintaining affordability for most Americans?Host Ed Crooks and regular contributor Amy Myers Jaffe of NYU are joined by Toby Rice, Chief Executive of EQT, one of the largest natural gas producers in the US. Toby argues that America has the resources both to meet rising domestic demand and to supply much more gas to international markets, without sending prices soaring. He sets out EQT's case for US gas to drive growth, affordability, reliability and geopolitical influence. He also makes the case for the environmental benefits of gas as a replacement for coal in power generation.The Trump administration often talks about “energy dominance”. Toby says. He prefers to describe the goal as “energy abundance”.US gas prices have been low by international standards for most of the past 20 years. The big question is whether that price advantage can persist, in the face of rising LNG exports and growing power demand from AI. Ed raises the prospect that continued growth in demand for gas could eventually push up domestic prices, weakening one of the US economy's biggest competitive advantages.Toby's answer is that the shale resource base is deep enough to respond. He argues that at the right price signal, producers can bring on enough supply to support both the domestic market and a much larger export system. He also makes the case that increased US LNG export capacity can strengthen American energy security by creating more flexibility in times of stress, rather than simply exposing Americans to global volatility. Amy highlights the increased global focus on energy security. If countries are becoming more anxious about imported energy after recent geopolitical shocks, will they still want more LNG, even if it comes from a reliable supplier such as the US? Or will they step up investment in domestic alternatives, including renewables, batteries, nuclear, and even coal?Finally, Toby talks about his work with Energy Corps, the nonprofit organization he founded to bring energy abundance to emerging markets. It aims to deploy technologies including renewables, gas and propane for clean cooking, to increase access to modern energy, and demonstrate ways to improve the quality of life for billions of people around the world.More information about Energy Corps is available at its website: www.energycorps.com This episode of Energy Gang is brought to you by ENGIE, the smarter energy supplier. ENGIE doesn't just provide the power to run your business — they supply the energy to move it forward, with reliable, flexible solutions built for what's next. Learn more at engieresources.com.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

If a great export distributor had four MedTech products to choose from today, why would they choose yours?MedTech manufacturers spend a lot of time asking whether a distributor is capable of selling their product. But there's another question that's just as important: why should a good distributor choose you? Taking on your product means investing their sales time, clinical resources, customer relationships, marketing activity and reputation. In this episode, Hakeem unpacks a real decision with experienced GCC distributor Sameh Salama to reveal what good export distributors actually look for before deciding whether a MedTech product represents a genuine commercial opportunity. Listen to this episode to discover:Why strong clinical evidence matters to export distributors but isn't enough on its own to create a compelling commercial opportunity.What good distributors assess before agreeing to represent your MedTech product—and why a distributor who challenges you can actually be a very positive sign.Why successful MedTech commercialisation and export depends on the manufacturer and distributor working together to create demand, rather than expecting the distributor to build the market alone. Listen now to discover what good export distributors really look for and how to make your MedTech product a commercial opportunity they'll want to invest their time, resources and relationships in.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Der Drohnen-Vorfall am Leipziger Flughafen Anfang August hat in Deutschland für Aufregung und Besorgnis gesorgt und eine Diskussion über die Abwehr solcher und hybrider Angriffe ausgelöst. Im Interview mit Host Stefan Niemann spricht der Sicherheitsexperte Nico Lange über die aus seiner Sicht immer noch mangelhafte Drohnenabwehr an deutschen Flughäfen. Man sei “an einer Katastrophe knapp vorbeigeschlittert, aber nicht, weil wir sie verhindert hätten oder abgewehrt hätten, sondern nur durch zufällige Umstände, möglicherweise einen technischen Defekt.” Der Gründer des Instituts für Risikoanalyse und Internationale Sicherheit (IRIS) bemängelt, die notwendige Sensorentechnik sei längst vorhanden, aber die Politik hinke hinterher. Daran ändere auch der neugeschaffene Nationale Sicherheitsrat wenig. Laut Lange passt die Sprengstoffdrohne zu Russlands gezielter hybrider Kriegführung gegen Staaten, die die Ukraine unterstützen. Deutschland müsse da deutlich wehrhafter werden. Man müsse damit rechnen, dass Russlands Machthaber möglicherweise noch in diesem Jahr testen will, ob die NATO wirklich zusammenhält, und zwar “nicht mit dem Angriff einer riesigen russischen Streitmacht, sondern mit einer Kombination aus hybriden und versteckten Angriffen und vielleicht kleinen, kurzen Vorstößen auf NATO-Gebiet.” Derweil geht der russische Angriffskrieg gegen die Ukraine unvermindert weiter. Die ukrainische Armee wehrt sich mit Attacken im russischen Hinterland auf Ölraffinieren und Lager des Versandhändlers Wildberries. Zugenommen haben in den vergangenen Wochen auch gegenseitige Angriffe auf Schiffe und Häfen, berichtet Astrid Corall. Dadurch leide der wichtige Export von Getreide. Ukraines Präsident Selenskyj hat nach eigenen Angaben den US-Amerikanern Vorschläge zur Beendigung des Krieges vorgelegt, Details sind bislang nicht bekannt. Er fordert aber erneut mehr Unterstützung bei der Flugabwehr – und bittet die USA, der Ukraine mindestens fünf Prozent ihrer Raketenbestände zu verkaufen. Astrid berichtet auch über Berichte, wonach Russland nach der Parlamentswahl im September eine Mobilmachung plant, über die gestiegene Zahl der im Krieg getöteten Zivilisten und sie wirft einen Blick auf die aktuellen Entwicklungen im Nahen Osten und in der Straße von Hormus.Lob und Kritik, alles bitte per Mail an streitkraefte@ndr.de Interview mit Nico Langehttps://www.ndr.de/audio-3417806.htmlAlle Folgen von “Streitkräfte und Strategien”: https://www.ndr.de/nachrichten/info/podcast2998.html Podcast-Tipp : REICH - Das Geschäft mit dem Zweifel:https://1.ard.de/REICH

Sechs Jahre ohne Wachstum, Industrieproduktion zehn Prozent unter Vorkrisenniveau, Wachstumsimpulse nur noch vom Staat: Rürup und Hüther diskutieren, ob Deutschlands Geschäftsmodell noch eine Zukunft hat.

Heute geht es ins Remstal, nach Großheppach zum Weingut Bernhard Ellwanger. Mein Gast ist Sven Ellwanger, der den Betrieb gemeinsam mit seiner Schwester Yvonne führt. Auf den ersten Blick wirkt dieses Weingut bodenständig, gewachsen und angenehm unaufgeregt. Im Gespräch zeigt sich aber schnell, wie viel Bewegung in diesem Betrieb steckt: Sauvignon Blanc, Junges Schwaben, Bio-Weinbau, Piwis, Spontangärung, starke Privatkundschaft, Rotweinambition – und eine Region, die noch immer mit alten Klischees zu kämpfen hat. Im Zentrum der Episode stehen drei Weine: ein Muskat-Trollinger Rosé, ein Roter Riesling und eine Lemberger-Syrah-Cuvée. Der Muskat-Trollinger Rosé zeigt, dass Duftigkeit, Frucht und Leichtigkeit nicht banal sein müssen. Sven beschreibt ihn als einen der wichtigsten Weine des Betriebs – trocken ausgebaut, aromatisch, frisch und mit einem kleinen Anteil maischevergorener Partie, der dem Wein zusätzlichen Grip gibt. Der Rote Riesling erzählt eine besondere Geschichte: Im Weinberg wurde eine Mutation in einer alten Rieslinganlage entdeckt – eine Fruchtrute mit weißen Rieslingtrauben, eine andere mit rötlichen Beeren. Aus diesem Zufall wurde eine eigene Selektion, die heute als ernsthafter Wein im Sortiment steht: körperreicher, fülliger und säureärmer als klassischer Riesling, aber dennoch mit eigener Riesling-Prägung. Die Lemberger-Syrah-Cuvée führt schließlich mitten in die Frage, wie sich Württemberg heute verändert. Lemberger bringt kühle Beerenfrucht, Frische und regionale Identität; Syrah ergänzt Würze, Körper, Pfeffer, dunklere Noten und Struktur. Im Glas begegnen sich regionale Herkunft und internationale Rebsorte erstaunlich selbstverständlich. Außerdem sprechen wir über Svens Zeit in Neuseeland, Sauvignon Blanc und Fumé Blanc, über die Gruppe Junges Schwaben, über Bio-Weinbau, Bodenaufbau, Humus, Begrünung und Pflanzenschutz, über den Gravitationskeller, über ProWein, Wine Paris, Export, alkoholfreie Produkte und die Zukunft eines Familienweinguts mit großer Sortenvielfalt. Eine Folge über ein Württemberg, das sich leise verändert hat – pragmatisch, beharrlich, bodenständig und im Glas sehr überzeugend.

Thinking about exporting your MedTech product to the GCC? What if finding a great distributor is only the beginning of what you need to succeed?The GCC can be an attractive export market for MedTech companies, but you can't simply take the strategy that worked in the UK, Europe or US, appoint a distributor and expect the same results. In this episode, Hakeem speaks with GCC MedTech distributor Sameh Salama about what manufacturers need to understand before entering the region, from choosing the right commercial partner and navigating local purchasing dynamics to clinical education, KOL engagement and supporting your distributor after launch. By listening you'll discover:Why the GCC isn't one MedTech market and what manufacturers need to understand before choosing where and how to enter. How to choose a distributor with the right portfolio, relationships and capacity to successfully commercialise your MedTech product. Why successful MedTech export requires an ongoing partnership between manufacturer and distributor, including clinical education, training, market development and clear activity plans that lead to sales. Listen now to learn how to commercialise and export your MedTech product successfully in the GCC by choosing the right partner, supporting them effectively and building the market for long-term adoption and growth.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Stephen speaks to Sim Tshabalala, Standard Bank Group CEO, about the bank’s record first-half performance, with headline earnings rising 10% to R26.1 billion and return on equity reaching 19.8%. Africa Regions contribute 40% of group headline earnings, while South Africa delivers R13.4 billion, as Standard Bank points to stronger client-led growth, lower credit losses and disciplined cost management. In other interviews, Barbara Creecy, Transport Minister talks about how Transnet plans to keep cargo moving during the upcoming peak fruit export season, the lessons learned from last year's severe disruptions, and whether the port is ready to handle increased volumes efficiently and avoid a repeat of the costly delays that hurt exporters. The Money Show is a podcast hosted by well-known journalist and radio presenter, Stephen Grootes. He explores the latest economic trends, business developments, investment opportunities, and personal finance strategies. Each episode features engaging conversations with top newsmakers, industry experts, financial advisors, entrepreneurs, and politicians, offering you thought-provoking insights to navigate the ever-changing financial landscape.    Thank you for listening to a podcast from The Money Show Listen live Primedia+ weekdays from 18:00 and 20:00 (SA Time) to The Money Show with Stephen Grootes broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/7QpH0jY or find all the catch-up podcasts here https://buff.ly/PlhvUVe Subscribe to The Money Show Daily Newsletter and the Weekly Business Wrap here https://buff.ly/v5mfetc The Money Show is brought to you by Absa     Follow us on social media   702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/CapeTalk 702 on YouTube: https://www.youtube.com/@radio702   CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/Radio702 CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

With 300 truckloads of vegetables crossing the border daily, Richard Lee, executive director of the Ontario Greenhouse Vegetable Growers, outlines why protecting stable access to U.S. consumers directly supports affordable, year-round produce for Canadians.See omnystudio.com/listener for privacy information.

Stephen Grootes speaks to Barbara Creecy, the Minister of Transport, about how Transnet plans to keep cargo moving during the upcoming peak fruit export season, the lessons learned from last year's severe disruptions, and whether the port is ready to handle increased volumes efficiently and avoid a repeat of the costly delays that hurt exporters. The Money Show is a podcast hosted by well-known journalist and radio presenter, Stephen Grootes. He explores the latest economic trends, business developments, investment opportunities, and personal finance strategies. Each episode features engaging conversations with top newsmakers, industry experts, financial advisors, entrepreneurs, and politicians, offering you thought-provoking insights to navigate the ever-changing financial landscape.    Thank you for listening to a podcast from The Money Show Listen live Primedia+ weekdays from 18:00 and 20:00 (SA Time) to The Money Show with Stephen Grootes broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/7QpH0jY or find all the catch-up podcasts here https://buff.ly/PlhvUVe Subscribe to The Money Show Daily Newsletter and the Weekly Business Wrap here https://buff.ly/v5mfetc The Money Show is brought to you by Absa     Follow us on social media   702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/CapeTalk 702 on YouTube: https://www.youtube.com/@radio702   CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/Radio702 CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

If your MedTech product isn't selling as quickly as expected, are more salespeople really going to fix the problem?When a MedTech launch underperforms, hiring more salespeople, recruiting another distributor or attending more exhibitions can feel like the obvious answer. But if the market hasn't been prepared and customers don't yet see a compelling reason to change, more sales activity won't solve the underlying problem. In this episode, Hakeem explains why successful MedTech commercialisation and export starts long before launch—and why understanding and preparing your market can save you from trying to force adoption later.In this episode you'll discover:Why MedTech commercialisation should begin months before your product launches, rather than after regulatory approval.Why adding salespeople or export distributors won't fix a market that isn't ready to adopt your product.How understanding what keeps your customers awake at night can help you create demand, prepare the market and accelerate adoption.ActionListen now to learn how to prepare your market before you commercialise or export your MedTech product, so your sales team can convert demand rather than having to create it from scratch.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

We hear the latest on the agreement to export prisoners from Sweden to Estonia. Also, we take a behind-the-scenes look at the Radio Sweden's exclusive party leader interviews in English and hear where the Swedish Football Association stands on the chaos surrounding Fifa president Gianni Infantino.Finally we head to the Old Town in Stockholm to find out what visitors think of Sweden. Presenters: Dave Russell and Liv Lewitschnik.Producer: Kris Boswell.

Send us Fan MailStay Connectedhttps://www.commstock.com/https://www.facebook.com/CommStockInvestments/https://www.youtube.com/channel/UClP8BeFK278ZJ05NNoFk5Fghttps://www.linkedin.com/company/commstock-investments/

As high gas costs pile up for drivers, Big Oil is getting jumpy. That's because one way to bring prices down, at least temporarily, is an oil export ban. The Trump administration hasn't signaled support for such a ban, but oil firms are being proactive, by lobbying the White House to find alternatives. Also in this episode: CEOs are sour on this economy, a major university invests big in artificial intelligence, and we analyze the difference between Fed Chair Warsh and former Fed Chair Powell's public statements.Every story has an economic angle. Want some in your inbox? Subscribe to our daily or weekly newsletter.Marketplace is more than a radio show. Check out our original reporting and financial literacy content at marketplace.org — and consider making an investment in our future.Read the stories in today's episode:Big oil is not up for another export banCan you spot the difference between Warsh and Powell's FOMC statements?Why you should care about CEOs' confidence in the economyThe FIRE movement: How soon can I quit?USC pushes to expand AI research with $200 million gift

As high gas costs pile up for drivers, Big Oil is getting jumpy. That's because one way to bring prices down, at least temporarily, is an oil export ban. The Trump administration hasn't signaled support for such a ban, but oil firms are being proactive, by lobbying the White House to find alternatives. Also in this episode: CEOs are sour on this economy, a major university invests big in artificial intelligence, and we analyze the difference between Fed Chair Warsh and former Fed Chair Powell's public statements.Every story has an economic angle. Want some in your inbox? Subscribe to our daily or weekly newsletter.Marketplace is more than a radio show. Check out our original reporting and financial literacy content at marketplace.org — and consider making an investment in our future.Read the stories in today's episode:Big oil is not up for another export banCan you spot the difference between Warsh and Powell's FOMC statements?Why you should care about CEOs' confidence in the economyThe FIRE movement: How soon can I quit?USC pushes to expand AI research with $200 million gift

Are you pricing your MedTech product based on evidence and value... or simply making an educated guess?Pricing is one of the most important commercial decisions you'll make, yet many MedTech founders spend years developing their product and only a few hours deciding what it's should cost. In this episode, Hakeem shares a practical five-step framework to help you understand your market, quantify your value, validate your pricing, and develop a pricing strategy that supports successful commercialisation and export.In this episode, you'll discover:Why competitor pricing should inform your thinking, but never determine your pricing strategy.How to assess the value your MedTech product creates and use it to justify your price.A practical framework for validating your pricing with clinicians, procurement teams, distributors, and customers before commercialisation and export.Listen now to learn how to price your MedTech product with confidence, strengthen your commercialisation strategy, and avoid costly pricing mistakes before entering new markets.If you need help with your pricing, message me on linkedin with the words "pricing supportThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Agriculture and Consumer Affairs Correspondent, Aengus Cox has the latest on the decision by Brittany Ferries to cease transport of livestock out of Ireland.

It's like Mo from Deft Brewing had a Machiavellian plan when I mentioned this beer on Tuesday. He knew, what he was doing when he brought MacDeft Scottish Eport today.

Rural news and events from Tasmania and the nation.

Send us Fan MailStay Connectedhttps://www.commstock.com/https://www.facebook.com/CommStockInvestments/https://www.youtube.com/channel/UClP8BeFK278ZJ05NNoFk5Fghttps://www.linkedin.com/company/commstock-investments/

We’re excited to have Will Loux, senior vice president of global economic affairs for the U.S. Dairy Export Council, join us to share his presentation of the future of U.S. dairy exports. For years, the U.S. dairy export portfolio has leaned heavily on nonfat dry milk, skim milk powder, lactose and lower-protein whey products. But our exports are changing. In the latest episode of The Milk Check, host Ted Jacoby sits down with Will Loux to break down the changing U.S. export picture. In this episode, we cover: Why U.S. dairy exports are moving toward cheese, fats and higher-value proteins How domestic protein demand is pulling skim solids away from dryers Why more cheese may be produced partly to create additional whey protein How exports are absorbing a larger share of new U.S. cheese production Where Latin America offers room for additional cheese growth What it will take for U.S. butter exports to become more consistent and profitable The U.S. has the milk. It has new processing capacity. And it is capturing a growing share of international cheese demand. But growth creates new challenges. Are you ready to meet them? Listen to The Milk Check episode 104: Can the U.S. Keep Its Dairy Export Advantage? Also available on: Amazon Music, Apple Podcasts, Spotify, and YouTube. Got questions? We'd love to hear them. Submit below, and we might answer it on the show. Ask The Milk Check Transcript: Ted Jacoby III: [00:00:00] Coming up on the Milk Check. Will Loux: What I’ve heard from folks in Europe and elsewhere is how do they manage the U.S. tsunami of exports that’s coming? And I think that, at the Export Council, it makes me excited, but it does mean we need to keep our strategies current. Ted Jacoby III: Welcome to the Milk Check from T.C. Jacoby & Co., your complete guide to dairy markets, from the milking parlor to the supermarket shelf. I’m Ted Jacoby. Let’s dive in. Ted Jacoby III: Today, we are very excited to have Will Loux, Senior Vice President of Global Economic Affairs for the U.S. Dairy Export Council joining us.  A few weeks ago I saw a presentation that Will gave that talked about where the U.S. dairy industry is going, especially from an international perspective. It was an absolutely fantastic presentation, and I couldn’t help but think that just this presentation alone would be an absolutely fantastic topic for our podcast.  I have a bunch of our traders joining us, many of our usual suspects, including: Ted Jacoby III: Diego Carvallo, Joe Maixner, Miguel Aragon, Mike Brown, all from our trading team. Guys, thanks for joining us. Will, thank you so much for joining us. It’s great to see you again. Will Loux: Good to see you, Ted. Thanks for having me on. Ted Jacoby III: Excited to have all of our listeners listen to this. Will, the floor is yours. Will Loux: Perfect. Well, thank you for having me, Ted, and glad to have so many people on here and another audience for this presentation. I’ve got some slides. For those of you like me who will listen to this podcast usually while driving, feel free to go check it out on YouTube. I am also gonna do my best to reference what is in those slides as best I can remember to do so. But what is the future of U.S. dairy exports? What we’ve seen, really over the last twenty-five years, has been this tremendous, consistent growth, in aggregate U.S. dairy exports. We just got May data, and what we saw was on an annualized basis over the last twelve months, the U.S. actually set a new record again. So our exports have never been higher than they are today. But that said, our exports look fundamentally different than what they did 20 years ago. Before, when we were getting started with exports, 75, 80% of our exports were really driven by nonfat dry milk, and low-protein whey products, and lactose. That’s been the vast majority of our portfolio for much of this time, and we’ve had a few different eras where we’ve seen U.S. cheese exports picked up, especially around 2014 when the world was short of milk and we saw U.S. cheese and butter go overseas. But then we saw that stagnate for a few years. Now, what we’ve seen since COVID has been this tremendous growth of these more value-add products, these specialty products. I believe the U.S. is moving towards a portfolio in the export market that looks a lot like cheese, fats, and proteins. And that’s gonna be the core of our exports, I think, going forward because the U.S. dairy industry is really kind of, I consider it an evolution rather than, like, a true revolution. But this is one of those facets that I think is really interesting to see is the U.S. has consistently been growing its exports, unlike a [00:03:00] lot of other supply origins. But this is one that I think as we go forward I’m really excited about. But it’s gonna change how we need to think about exports over the next few years. Ted Jacoby III: Will, it sounds like what you’re saying is not only are we seeing the total volume of exports go up, but the dollar per pound value is even going up faster because we’re switching away from that low-cost carb portfolio to a much higher-value protein, fat, et cetera portfolio. Fair to say? Will Loux: I think that’s exactly right. I think there are implications for that, too.  That if the U.S. is moving out of perhaps exporting as much skim milk powder or sweet whey because we’re instead making UF milk or cottage cheese or yogurt or high-protein whey, well, there’s still demand overseas for that sweet whey and for that skim milk powder. But now, it’s actually getting supplied by a few other countries, too. So, we do have to keep all of these things in mind. But to me, I think we’re moving up the value chain as the U.S., and what I’ve heard from folks in Europe and elsewhere is how do they manage the U.S. tsunami of exports that’s coming? And I think that, at the Export Council, it makes me excited, but it does mean we need to keep our strategies current with where we’re gonna go in the future. One of the things that I’ve noticed here over the last really few months but even going back to last year has been a real shift in how the U.S. dairy market is balancing itself. I would argue that for the last really 20 years, to be frank, but at least for the last 15 years, the U.S. dairy market has largely been balanced to domestic fat demand. Yes, we did see, certainly, exports of cheese grow over this time, so I don’t want to discount that as a butterfat-heavy product, but for the most part, what we’ve seen has been the U.S. has consistently balanced with where domestic demand for butterfat has grown, and then we’ve exported the skim solids largely in the form of nonfat dry milk and sweet whey overseas. What we’ve seen here over the last several years has been the U.S. switching from a traditionally balancing to domestic milkfat demand, where we’ve seen butter consumption grow, whole milk consumption grow. U.S. milk production, U.S. dairy production grew with that. And then, we exported the additional skim solids in the form of nonfat dry milk, sweet whey, high protein whey, lactose. Those products were the ones that we were really exporting. Now, what I think is happening is the U.S. is no longer really balancing to fat anymore. We’re in this precarious balance right now. We’re not quite balanced to protein yet, and we’re not quite balanced to the beef market yet because we still have high prices for protein. We don’t have enough of it to go around. We don’t have enough beef for the beef market to go around, but we also have more milk fat than the domestic market can consume. And so we’ve seen these exports really rise. So, I think what we’re seeing right now is the U.S. being pulled in different directions, and the U.S. exports as we go forward here over the next few years is in some ways at a crossroad as to which of these routes do we go. Do we swing back to balancing to milk fat, which would mean we’re probably short of protein, or do we start balancing more to protein, which means we’re gonna need to find homes for a heck of a lot more cheese and butter in the next few years. [00:06:00] Because to me, at least, if you look at the beef market, from a dairy farmer’s perspective, you are still seeing that incentive to add additional cows just based on the returns on the beef side of things. And because of that incentive to hold the dairy cows longer to get the additional black calf, also with that breeding the best of the best in the young stock, we are just seeing the largest milking herd since the 1990s and the lowest replacement herd since the 1970s. And everything we’re seeing on the beef cattle side of things would suggest this isn’t slowing down anytime soon. But from the U.S. perspective, I think what this means is we’re gonna continue to see more milking cows around, and those cows are getting more productive than ever before. And even as we’re seeing this surge in milk production, I think on a component basis, last year in in 2025 we were up 3.8%. This year we’re up not quite at 3%, but still pretty darn close. Even as we see this growth of milk, these additional black calves coming on the market, we actually still don’t see enough protein hitting the dairy markets right now. And so, what we’re seeing is even as we see this huge surge in cottage cheese production and yogurt production, my personal opinion is yogurt doesn’t get enough credit for this protein rally. It’s like 10X the volume of cottage cheese, but what we’re seeing right now is this pull of protein. I think this pull of protein is predominantly domestic. We’re seeing UF beverages, we’re seeing yogurts, we’re seeing cottage cheese, we’re seeing everything that whey protein can go into from cereals to snacks to beverages. All of that protein pull is basically sucking protein and skim solids that had been going to the export market back into the U.S. By virtue of that, we’re also seeing U.S. cheese production need to increase, not so much for the cheese demand that we’re seeing here in the United States, but rather for the whey demand that we’re seeing here as well. The cheese has really become that co-product of the whey stream. I think even conversations that I’ve had with U.S. manufacturers of, “How can I get more whey protein without building a new cheese plant” is part of the consideration. One of the things that we’ve looked at over this time has really been where is this protein in the United States going? Because we’ve seen U.S. milk production rise, U.S. milk protein production rise in the sense of protein out of the cow, but we still have less nonfat dry milk and skim milk powder than we had a year ago. What I’ve noticed over this time has been certainly the cheese vat continues to get first dibs on most of that protein. Even in the May data that we got out of USDA, you saw cheese production was up, even when nonfat dry milk was sitting at sky-high levels north of $2.00. What we’re really seeing right now is we’re pulling milk out of the dryers and either putting it into the cheese vat or putting it into these other high-protein products and the like. What that is doing is that’s shifting our export mix. So far this year, our exports of skim milk powder, amazingly, are flat somehow. But if [00:09:00] you look at our May exports of nonfat dry milk and skim milk powder, they were down 20%, and I think that’s reflective of that, and we were down last year. What we’re seeing has been the U.S. is moving out of some of these carb-heavy, as you talked about, Ted, to these more higher value uses for these products. And even nonfat dry milk production picked up in May, but it’s not that we pulled milk out of the yogurts or out of the cottage cheese or out of the natural cheese itself, it’s that we stopped making skim milk powder and instead made nonfat dry milk. This is really where we’re seeing this pull of protein, either in the form of beef necessitating more cows or necessitating more capacity to make whey proteins, milk proteins, UF products, or just high-protein dairy products. All of that pulled together is sending a, “Let’s go make more milk.” Contrasting that, you have cheese and fats, which at this point right now, and historically this isn’t too unusual, but it is something different than we’ve really seen over the last few years, has been this export push of cheese and dairy fats in the form of predominantly butter, AMF, and to a lesser extent whole milk powder. What we’re seeing here has really been this shift where right now I think we’re growing our milk production as fast as the international market can absorb our cheese and fats. Because if you look here, since COVID, what we’ve seen is about 36%, over a third of the new cheese that’s been manufactured in the United States, has gone to export. If you think about that historically, about 5% of the new cheese in the previous decade went to exports. And now we’re at 35%. And if you look at the last two years, it’s north of 65% has gone to exports. As we’re building these new cheese plants, in part for the whey, there is that eye towards, “Okay, where are we going with this cheese?” And it’s gotta be overseas. Within that, too, the United States is actually the one capturing what is a growing global market. It’s not just that the U.S. is flooding the market with less expensive cheese, it’s that global cheese demand is growing, and the U.S. is the one capturing that. Because if you look, since COVID, the U.S. has captured about 60% of that new cheese demand that’s happening overseas, and that’s really been coming from the United States. Europe’s grown their cheese exports too, so has New Zealand. Australia’s basically flat, but the rest of the world evens up. The difference here is that the United States is really the one capturing this demand growth because we have the milk, we have the cheese, and that’s really where I think the U.S. has managed to expand its footprint, be a more consistent exporter, and really break into new markets that it hasn’t before. But we’ve been in cheese for a while. Granted, it’s at a different scale today than what it has been. We were up 20% last year in cheese exports. This year we’re up about 25% so far this year. We continue to surge in our cheese exports. The difference that is new this time around is, fundamentally, that we’re seeing this expansion come not [00:12:00] just in cheese as our primary vehicle to export the fat and casein, but also in fat-heavy products, predominantly butter, but also AMF and whole milk powder, too. That you’re seeing the United States now, for every, load of high-protein beverages, you’re gonna have a load of cream that you’re gonna need to deal with, or multiple loads of cream that you’re gonna have to deal with, and that’s now going overseas. Domestic demand for butter is still going strong. Domestic demand for whole milk continues to grow. The difference is we’ve just grown production faster than that domestic demand. And so, you pull this all together, and I really think we’re seeing an evolution in our portfolio for exports. Cheese by value is now our biggest export product, and you’ve seen fats and proteins continue to grow within that portfolio, as well, from a value perspective. While we’ve seen nonfat dry milk, low protein whey, lactose, those have really been flat to declining over this timeframe. And so, if you look at that incremental growth that we’ve seen in our U.S. dairy exports since COVID, again, what we’ve seen is our two biggest stars during this period have been cheese and fats, and I think protein in the long run is still really optimistic to me. But you pull this all together, the U.S. is still gonna be a major player in skim milk powder, sweet whey, whey permeate, lactose. But if you look at where our exports are gonna grow in the future, those are really some of the key products. What do you all think about this as kind of a argument here for where our U.S. dairy exports are going? Joe Maixner: That’s been exactly what we’ve been discussing for the past six plus months, that our supply is going to continue to outpace the domestic demand. So 100% agree with everything you said in this, Will. I think that butter will continue to become a major player in the export market. Miguel Aragón: In my case, being out there in the trenches, I see this day in, day out. The penetration of U.S. cheese and butter, especially right now. We know the soaring ingredients, but cheese and butter especially, every day you could see it more and more in the marketplace. Something really interesting that you said at the beginning: If we’re gonna produce more cheese, we’re gonna have to find a place for it. We know the numbers, we see the numbers. It’s an amazing story. But right now, as we speak, that is replicating in Central America. You guys see it at the U.S. DEC. And I just came back from Colombia. The opportunity is there for us, as long as we keep doing what we’re doing now and looking at the market, adapting to the market, adapting to what the market is asking us for, and also replacing some of the product that is coming from Europe and New Zealand. But I agree with what you’re saying here 100%. Ted Jacoby III: Will, I’m gonna turn the question around on you a little bit. Is the global demand for butterfat there for us to continue to increase how much butter we’re exporting? And is the global demand for cheese there? Will that global demand keep increasing for those two products? Will Loux: From my perspective, it’s yes. What I find interesting over the last couple years has been that [00:15:00] cheese demand held up exceptionally well even during high inflation periods. Where we saw other dairy products actually feel a lot of the pressure internationally, cheese demand kept growing pretty much right on track. What we’ve seen here on the cheese side over the last couple of years internationally has been this acceleration in cheese demand, and I think some of that has to do with, as Miguel was saying, tremendous growth from our partners in Latin America. That’s been a key engine for U.S. dairy exports here over the last couple of years and, frankly, since the Export Council was founded about 30 years ago. But when we look at the opportunities abroad, I think that we still have a lot of untapped potential on the cheese side. I remain pretty optimistic about that. The other thing I’ll say, too, here is: I don’t think European milk production’s gonna keep growing at 3% a year. I don’t think you’re seeing the same investment in new cheese capacity. I think we’re seeing investment in Europe and New Zealand in new protein capacity, and that’s maybe another conversation. But I think the U.S., one, has the opportunity to capture what is a growing global market on the cheese side, and also capture market share on the cheese side. The butter standpoint has been interesting. Butter has typically been, internationally, one of the more price-elastic products. It’s one that we’ve seen when butter prices really skyrocketed, some of that may be allocation, but when butter prices were high, we did see international demand struggle. Conversely, when butter prices were low, like they are today in many ways, we’ve seen butter demand grow. And butter demand internationally is growing, not just out of the U.S., but globally. I think the question I have here with butter is less about can the U.S. compete in this market, but more, what is our price point relative to Europe and New Zealand. Because I think if you look at our butter exports, for much of last year we were probably a buck a pound below Europe. A lot of that butter was going into Europe, where coincidentally the tariff into Europe is about a buck a pound. I think my question is more crucially than can the U.S. capture growing demand for butter, it’s where do we grow our butter exports. And I, personally, think the U.S. should never be exporting really butter to Europe unless we get additional market access. I think the U.S. should be exporting butter to its higher value markets and partners, places like Mexico, like Central America, North Asia and Korea, Australia, the Middle East, assuming we can keep the strait open for a little while. But I still remain pretty optimistic that the U.S. can keep growing in those products. Some of it will be market share, and some of it will be new demand, particularly on the cheese side. Ted Jacoby III: Will, looking at this graph where it’s talking about, U.S. dairy exports by destination, there’s a big increase into Latin America since 2021. Will Loux: Yep. Ted Jacoby III: Is that fair to say most of that is cheese? Will Loux: It’s fair to say most of it is cheese. We have seen increases also in nonfat dry milk and skim milk powder exports to Latin America over this timeframe, too, but the big driver, I think especially post-COVID in Latin America, was, [00:18:00] one, that region was the first major region, I should say, where tourism increased to levels higher than what it was before COVID, and we continue to see pretty good economic performance in the region. The other thing I don’t wanna discount here, too, has also been the full implementation of CAFTA-DR, our trade agreement with many of the Central American countries came into full effect, and you’ve seen this real surge in demand from the region and collaboration with our local partners there, that we’ve really seen this growth in Central American demand and Caribbean demand. Most of that is cheese. More recently, there are also butter and AMF and so going there too, but cheese has been the engine on the Latin American side most recently. Mike Brown: Will, I’ve got a question. Anything in particular we in the dairy industry, and of course you at U.S. DEC, are watching as far as improving opportunities, but also possible disadvantages we may gain through trade. Will Loux: Yeah. Great question, Mike. I have a mix of optimism, and then probably a couple notes of caution on this. So from my optimistic take, a lot of these new agreements on reciprocal trade that we’ve signed with key partners around the world, some of these are incredibly exciting because these are markets we’ve wanted to have agreements with for a long time. In particular, Indonesia makes me very excited. I think if we are able to see that actually be implemented here soon, I would be even more excited. I think there’s still a question on when that gets fully implemented. Taiwan is another one. We are getting access into markets that we never had access to before. We’ll see when those are fully implemented but again, I am still pretty optimistic on where those have opportunities for the U.S. to build upon and get on an equal footing with our competitors in Oceania and in Europe. However, our competitors are not staying static. We see a new agreement here between the European Union and Mexico. We have an agreement between the European Union and Mercosur that gets them additional access, particularly in proteins. I think the U.S. cannot take its customers for granted. Especially as we look at places like Mexico, that’s one where competition is not going to go away. And when we’ve seen nonfat dry milk sit 75 cents plus above Europe, you’re gonna see customers start calling Europe and New Zealand and looking for alternative sources. Or when we have high-protein whey products that are in such demand domestically, are we making sure we’re contacting our customers abroad? Because what we’re seeing now is Europe is heavily investing in additional whey protein capacity. Even as the U.S. is the largest exporter of high-protein whey in the world, I think there are other origins that are coming for that. And so, when I look optimistically, it’s like, “Great, we get more market access.” But to some of the key questions that I have around like is the U.S. ready for the future of dairy exports, one of them is gonna be: How do we actually meet this international demand on the protein side, and are we gonna have the market access that we need to be able [00:21:00] to capture sales? As I look at the world market today, I have a ton of optimism for where the U.S. can really be the supplier of choice, but it’s not gonna be a straight line from here to there, even on the fats or even on the cheese. I think the last couple years, milk production’s been up so much, it’s allowed us to capture a lot of demand, but even those I think will bounce around. Mike, I don’t know if that answered your question, but that was where my head’s at these days. Ted Jacoby III: Everybody, we will be right back after these messages. Diego Carvallo: I’m Diego Carballo with T.C. Jacoby & Co.. T.C. Jacoby & Co. specializes in international dairy markets. For new customers that haven’t done business with Jacoby, I would tell them that we can provide them with many of the powders, dairy products that they consume, not only with the physical product, but we can also help them mitigate their risk. We know dairy. We know the main players. We know the main providers for the whole value chain. We are one of the strongest players in the U.S. market because we have contact all the way from the farmer moving the liquid milk all the way to the end users that buy the end products. I am Diego Carballo with T.C. Jacoby & Co., and we bring dairy to the world. Will Loux: Ted, maybe what do you think if we go through a couple of these questions and have a little debate? Ted Jacoby III: All right. We’ll ask our team. Number one, does the U.S. have the necessary market access and global reach to capture sales opportunities in a multipolar world? Will Loux: And maybe I’ll clarify what I mean by multi-polar world. Ted Jacoby III: Great idea. Will Loux: Cause what I mean by that is if you look at global dairy trade leading up to COVID especially, from 2010 to 2020, China was the engine of that global dairy import demand growth. They accounted for 40% of that growth. These days, I’m not particularly optimistic China’s gonna be the engine. I think China will be an important import market, for sure. And I think they’re still gonna need fats, they’re still gonna need proteins, but they’re growing their own domestic supply, particularly of commodities. So, what I think the future looks like from a demand perspective is collective growth. Latin America, Southeast Asia, Middle East, North Africa, Sub-Saharan Africa even, I think there will be a lot of countries growing that collectively equal what China was doing before. But we’re gonna have to play in a lot of markets. So, the question to you guys then is: Do we have the reach and access to be able to compete in a lot of different places, or what does that look like for the U.S.? Because China is not gonna be the engine of global dairy demand here over the next decade, we’re gonna have to compete in a lot of different markets. In the previous decade leading up to COVID, you saw a lot of the New Zealand milk production, an increasing percentage was going to China, which opened up opportunities for us in Southeast Asia and the Middle East and others.  As we look at this next era of dairy exports, do we have the market access? Do we have the global reach and infrastructure to be able to capture sales in a lot of different markets [00:24:00] around the world? Diego Carvallo: That’s a good question. If we start with the premise that the U.S. is not gonna desperately need to export nonfat, I would say that it’s not gonna be that difficult to find new markets. The U.S. is not gonna have to fight to move additional volumes like they need to do for products like butter. Where do we take the skim milk powder that we’re currently making if China is not a huge buyer anymore? There’s plenty of demand still to be covered in other regions of Southeast Asia in other regions in Latin America, where we should have a good footprint and where we should have some advantages when it comes to freight. I would say the main markets where we have to gain market share are gonna be definitely Central America, the Caribbean and Latin America because of all of the advantages when it comes to freight and the relationship and other factors. The market where we’re gonna fight with the rest of the origins is gonna be Southeast Asia, we may need to go there and fight with price, with aggressive pricing, and we may need to compete even with China, ’cause we’re hearing that even China has been exporting product to that region in the past year. There’s gonna be some markets where we are positioned to gain market share and others where we’re gonna have to compete in price. Ted Jacoby III: Miguel, what do you think? With cheese and butter, do we have the necessary market access and global reach? Miguel Aragón: We do have the necessary market access. Our products are welcome where we are taking them. Our issue is more like, the cheeses that we produce at scale, cheddar and color cheddar, are not necessarily the cheeses that our markets are asking for. We need Gouda, we need Monterey Jack, we need Sadero, we need Manchego. We need the help of our partners, our plant partners, to adapt and to see the opportunity of the cheeses that those markets ask for. And I’m in particular about Latin America. But then again, that’s a big market.  U.S. cheeses are well-received. We do have places to go with it. We just have to get better at exporting. U.S. DEC does a really good job at helping us get into those markets, vet the customers and teach about the products. We are doing the right things. We just need to do it a little bit better. We do have places to go with that extra cheese. Ted Jacoby III: Miguel, do you think there’s a lot of underserved regions in Central and South America? In other words, are there a lot of customers who the only reason they’re not buying and importing more U.S. cheese is because they don’t know who to buy it from, they don’t have the contacts? Miguel Aragón: I do. In the last trips that I made, especially to the northern part of South America, colombia, Peru, Ecuador, there is demand. It just reminds me of Mexico 15, 20 years ago. They don’t know who to buy it from. They don’t know that we make it. They don’t know that we have the variety that we have. It’s an education. We have to work, harder at marketing our products down there. But there is a place. There is definitely a place. There is a market. Ted Jacoby III: Thanks, Miguel. All right, Joe, I got a question for you. Can the U.S. export butterfat products consistently and in a [00:27:00] profitable manner? Joe Maixner: I think we’ve started showing that we can export consistently. Numbers have been pretty consistent and have been growing throughout the year. A profitable portion probably remains to be seen. We’ll always have to be aggressive as we’re entering into new markets ‘ cause we’re gonna have to find a way to penetrate into markets that have been historically dominated by Europe or Oceania with a product that does not look like Europe or Oceania’s product. The easiest way to do that, obviously, is to, for lack of a better term, buy our way into the market to people to try the product. But once our product is in there and they realize it’s a consistent quality butter, I think that we certainly have the opportunity to be profitable long-term. Realistically, exporting butterfat consistently makes everybody more profitable in the U.S. because it pushes fat offshore, which helps our butter price, ultimately, domestically. Will Loux: When I look at exporting butterfat profitably, for us, especially at the Export Council, it’s been one of those things that the U.S. for the longest time hasn’t had butter basically to export. When we’ve gotten long, we’ve found places to clear it. I think what’s changed this time around has been that it seems like with the pull of protein, that we’re gonna have at least some butter available long-term. The question that I still have is where are the best places for us to invest? And even as an Export Council, where are the best places for us to invest our resources into trying to make sure that customers even know that the U.S. has butter available to export, while also trying to find ways of helping U.S. exporters navigate different tariffs than they’ve traditionally had to export, making sure the product specs meet it, and then also trying to get new market access in places that, for a while we’ve seen a lot of trade agreements that thankfully got the U.S. access in cheese and in milk powders, and sometimes butter was in there, sometimes it wasn’t. And so how do we get additional access into that? I look at the U.S.-Japan phase one, that we got additional cheese access, I think we could use some additional butter access into Japan. I’m pretty optimistic on this one. I don’t know if we’re there yet, but I think it’s gonna be isolating which markets are going to be the most profitable for us. I’m probably less optimistic that we’re gonna be consistent in exporting butter here in the next couple of years. But long-term, I think it’s undeniable that the U.S. is gonna have to go in this direction eventually. Ted Jacoby III: Why are you less optimistic in the short-term? Will Loux: I’m a little optimistic in the short-term because we have been exporting effectively double the butter exports we have been. We’ve seen that gap between the U.S. and international markets close quite a bit. Inventories are pretty low. The milk fat test, until May, which surprised me a little bit, had been slowing down as farmers adjusted rations. If we get to the point where butter is $1.40, $1.50, I’m not sure it always makes sense for the farmers to pay for the incremental increase in feed inputs to boost the butterfat test to the [00:30:00] extent that would boost our exports. We may find ourselves tighter in butter in the fourth quarter because we’ve exported our way back to balance. And to me, it looks like where cheese was 15 years ago: That we are on the path towards being a consistent exporter, but we’re often still going to prioritize our domestic market. From the U.S. perspective, I think our butter looks like cheese did 15 years ago, where we’re often export competitive, but not always. Joe Maixner: Will, basically, you have summed up exactly what I’ve been saying for a while, where the butter export opportunity will be cyclical because we will get super competitive, which will drive our domestic price up, which will take us out of the market, and then in turn, cause a surplus of domestic butter to show up in the market, which will then collapse the price and make us super competitive again in the export market. We’re still early enough in the phase that we’re trying to figure out those cycles. I do think it’s cyclical. Overall, though, I do think we will be a consistent exporter. There’ll be a base, and it will ebb and flow, but I do think we will be a consistent exporter moving forward because as we’ve gained market share, we are getting loyal end-use customers in export markets that will consistently pay for our product. Will Loux: I 100% agree with that. I think it’s gonna be, where do we keep our consistent customers, and where are the opportunistic sales that maybe ebb and flow? That’s gonna be a multi-year process as that all shakes out as to where are our stickiest markets within all this? Mike Brown: You want those consistent customers. Jacoby, one of our jobs is helping people with those opportunities. So, they’re both important, but you still need that core base demand and respect for the product. And so, I have a question for you on this, Will. Let’s take butter. Butter’s a great example because the world is unsalted 82, we’re salted 80. I think Joe would attest: We’re seeing suppliers trying to be more flexible in making the product that meets that demand, yet on the other hand, if you’re gonna store a commodity, you gotta make the commodity that is the market product. What are you seeing as far as our adaptability to be that flexible supplier in the world market? What else do we need to do that maybe we aren’t currently doing? Will Loux: There certainly has been a lot of progress made. From my perspective, you have a few different things. One is, of course, the salted and the fat content in the U.S. is different. It’s rare that we’re gonna be exporting from our inventories of 80 salted unless it’s just purely a price play. But what I think about when I think long-term export opportunities is really targeting the key channels that the U.S. is likely to win in first. And some of that’s food manufacturing. I think that’s where the U.S. can be really good, especially making bulk butter for export. I think it’s the first channel. But then it’s also making sure our formats meet the expectations of the customers. Because food manufacturing, I think, will only get us so far. The next phase where the U.S. can really excel in a couple markets is in the foodservice space and in the bakery space, in particular. We have next to no [00:33:00] capacity in the U.S. to make butter sheets, basically the stuff that you would use for croissants or bakery applications. Those are things we know we’ve heard from customers on how we can make products that are specifically geared towards that. In the long run, those are some of the issues. Some of it’s also from an Export Council perspective, educating customers on why U.S. butter is a different color, helping them understand how to utilize it. And even if they choose to use 80%, how to adjust their formulations to that to help understand, “Hey, this is a simple difference of 2% fat difference.” We can work in that space here, too. Long term, I think the U.S. needs to be sure, and this is something we’ve seen in all the other export products that we’ve seen over the years, is not solely trying to sell what we make here in the U.S. and say, “Hey, you should try this instead.” But instead figuring out what our customers are asking for and really making that product. And a lot of that goes down to also the formats and trying to move beyond just bulk butter for further processing into really targeted markets with those specific products. Ted Jacoby III: Joe, do you think the butter industry will invest in those things to increase our capabilities to deliver what the customer wants? Joe Maixner: I think eventually they may have to if our fat components continue the direction that they’re going. Some of the forward thinkers will be the first to adapt, and they’ll be the beneficiaries of investing in some further processing type manufacturing to be able to account for that. Cause at the end of the day, the profit’s in the value add. It’s not in selling bulk.  If there’s production capacity, and there’s space to do the addition, and somebody has the foresight to take the chance on it, I think that the payoff is there. Because if you get into that food service type packaging or laminated butter sheets or you get into a product that nobody else is making, that makes you very sticky in that market. You own that market. Will Loux: Even as we’re talking about butter here, we’ve got to think of other, fat-heavy products that could actually play really well in the international market. I tend to think whether it’s, like a UHT cream product, I know there’s always interest in like a frozen cream product. That’s a hard thing for the U.S. to make in some ways. I think UHT creams, we continue to see grow even as we see UHT milk itself actually decline globally. But we’re seeing real interest in that food service sector of, “Hey, let’s get whipping creams that are really targeted towards some of these international markets.” As much as for the U.S. it’s geared around, “Okay, what’s the most storable form of fat?” I think that’s step one, to find a way to export it. But step two is really what are these value-add fat-containing products that we can actually be targeting and competing in as well. And then I think balancing to like an AMF or a whole milk powder, but then using our butter and creams for the value add opportunities. Ted Jacoby III: I agree. Joe Maixner: Let’s not forget cream cheese, either. Cream cheese internationally has been phenomenal. That has plenty of trajectory to keep going. Miguel Aragón: I [00:36:00] must agree 100% with what Joe was saying on cream cheese. We are seeing phenomenal requests for cream cheese throughout Latin America, now in Asia. As what you were saying about channels, Will, we are now working with retailers in Central America with butter. Right now, it’s food service packaging going into retailers, but I think that’s a very interesting thing happening because once those brands of U.S. manufacturers start showing up in the retailers, I think we’re gonna have a better pool of U.S. butter. Ted Jacoby III: I agree, Miguel. Will, I think we should move on to the next couple of questions.  – I’m gonna read them both out because I think they’re very related. The first question is, can the U.S. grow cheese exports fast enough to keep up with whey protein demand. And then the second question is, will the U.S. have the protein to supply both the rising domestic and international consumption? I’ll answer the Second question first, which is, my dad, one of the things he drove into us as traders was, at the end of the day, everything’s a matter of price. Which means supply and demand will be regulated by what the price of protein is in the global market. I think it’s fair to say Europe has a much greater ability to add whey protein processing than the U.S. does because a smaller percentage of the whey offtake from cheese plants in Europe is currently being processed into whey protein. So, we will see some pushback there. But in the end of the day, that’s simply gonna self-regulate over what that global price is. My prediction is, can the U.S. grow cheese exports fast enough to keep up with that whey protein demand? I think we are reaching a point where the U.S. is consistently priced where the world market is priced for cheese, and I think that is going to change the way new cheese plants get built because we have had pushback for for 40 years. It’s exactly what Miguel has been talking about, is you don’t make the cheese that we want. Well, if we’re consistently now priced properly into the international market, my challenge for the cheese industry is someone needs to build a plant that supplies the international market with what they want, because we’ve arrived at the point where we’re gonna be consistently competitive now, and that risk becomes worth it. Miguel, do you agree? Miguel Aragón: Totally. I couldn’t have said it better. The market is there; it’s waiting for us to take more of it, but we need the right product now. Ted Jacoby III: And I think that whey protein demand may actually drive someone to do it.  What do you think? Will Loux: I agree with everything you’re saying. I think these are two inextricably linked pieces. Right now the signals are such: “Make more whey protein capacity” is clear. There’s also an element of “make more MPC capacity” or “make more capacity with the skim stream targeting proteins” as well. I think what’s holding back some of this capacity to date is probably much more the profitability on the cheese and on the fat side, and where those prices are at. From the dairy farmer perspective of if they’re investing is, the dairy farmer getting the price signals on the protein side? Because right now they’re getting the [00:39:00] price signals on the cheese side and on the fat side, and those are saying not as much to grow. These all need to be put into the spectrum of like, if we successfully grow our cheese exports and keep that international price relatively firm and grow demand abroad for cheese, and grow demand abroad for fats, it’s clear to me the protein demand seems pretty much insatiable here in the U.S. I think there’s a ton of untapped demand internationally, especially as GLP-1s start launching internationally. Like, there is a lot of international demand that I don’t think the U.S. should lose sight of, particularly with regards to whey proteins and milk proteins and all these other products. But it comes down to: can we grow our exports of cheese and butter, not just where we’re setting the global price for those products, but finding ways to make that stream profitable internationally, just as we’ve made the protein stream now incredibly profitable from a whey protein perspective. Folks are gonna come, particularly in Europe, as you said, I think they’re manufacturing over a million metric tons right now of sweet whey in Europe. Some of that’s gonna go to high-protein whey products. We’re gonna have more competition in that space. We’ll see what the price ends up being. All of these things are inextricably linked. And when I think about the mandate here at the Export Council, it’s like, how do we grow those cheese, those fat, and those protein exports, to keep that profitably moving and continue that investment? Because demand’s there for protein, and we’re seeing good demand internationally for cheese. We’re moving the fat overseas. But how do we do that in the most valuable way possible, I think is really what’s gonna be that next era of U.S. dairy exports. Joe Maixner: Will, I’m gonna ask you a question, ‘ cause I’m gonna push back a little bit. You said that farmers aren’t seeing the signals because of cheese and fat. You don’t think a $17 plus Class III and an $18 Class IV basically for the next year, plus your return on beef, plus your cheap inputs on feed is not enough to get the farmers to expand? Will Loux: Oh, I think they will continue to expand. When the nonfat dry milk price shot up, I think that was a reflection that we were short on protein. That we pulled so much out of the dryer, that was that reflection. But I think as Mike even said on one of your previous podcasts, that it was really shown in the PPD rather than necessarily in the protein price. I don’t mean necessarily they’re not getting the signal, it’s just some of it’s our pricing system is a convoluted signal. Ted Jacoby III: Will, you’re speaking to the choir. Mike Brown: I’m gonna have to quote you on that one. Ted Jacoby III: I’m gonna take this opportunity to say, Will, thank you so much for joining us today. This has been a fantastic discussion. I hope you come back soon and join us again, because we always love having you on our podcast. Will Loux: Always fun being with you guys. Thanks for having me on. Miguel Aragón: Bye, guys. [00:42:00] End Commercial: Mike Brown: For one part of the supply chain to be successful, everyone has to be. My superpower is practical application of data and analysis. I believe firmly that Jacoby’s success is because we help our suppliers and our buyers be successful. I’m Mike Brown, and I love working for T.C. Jacoby & Co. because I get to help people make their businesses more successful.

New Zealand red meat exports were worth $1.37 billion in June, 50 per cent higher than June last year and a record value for exports over that same period, according to new data. The June result was supported by higher sheep meat and beef export volumes, as well as stronger global prices, while the full 2025/26 year also recorded a lift in overall export value. The Country's Jamie Mackay explained further. LISTEN ABOVESee omnystudio.com/listener for privacy information.

Can you help me make more podcasts? Consider supporting me on Patreon as the service is 100% funded by you: https://EVne.ws/patreon You can read all the latest news on the blog here: https://EVne.ws/blog Subscribe for free and listen to the podcast on audio platforms:➤ Apple: https://EVne.ws/apple➤ YouTube Music: https://EVne.ws/youtubemusic➤ Spotify: https://EVne.ws/spotify➤ TuneIn: https://EVne.ws/tunein➤ iHeart: https://EVne.ws/iheart BYD JULY SALES HIT 419,211 https://evne.ws/w1k09 CHERY EXPORTS TOP 200,000 IN JULY https://evne.ws/l4nft GEELY JULY SALES HIT RECORD ON EXPORT BOOM https://evne.ws/clwkq LEAPMOTOR TOPS 100,000 JULY DELIVERIES https://evne.ws/myzb0 NIO SETS AUGUST DEBUT FOR FIFTH-GEN SWAP https://evne.ws/d4rnr XIAOMI EV JULY DELIVERIES TOP 30,000 https://evne.ws/t3gan ZEEKR HITS FOURTH MONTHLY DELIVERY RECORD https://evne.ws/b005h CHINA SETS EV BATTERY HEALTH DISPLAY STANDARD https://evne.ws/1ls6r BYD BATTERY ROW SHIFTS TO POLICE https://evne.ws/c1w2j

In this episode of Author Interviews from the Society for Neuro-Oncology journals, Dr. Jiasen He (UT MD Anderson Cancer Center) speaks with Dr Stephen C. Mack and Dr. Kelsey C. Bertrand from St. Jude Children's Research Hospital about their recently published article in Neuro-Oncology titled 'Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma Authors: Stephen C. Mack, Kelsey C. Bertrand Interviewer: Jiasen He

The gang dives in to Snake Island and everything coming in 12.1!Blizzard Acts in GM Power Abuse IncidentLast week, we discussed the known details around an apparent abuse of admin powers. This week we get to tell you the fall out. The Blizzard employee was found to be in violation of their Code of Conduct and was dismissed from the company immediately.The players who were found complicit in the violation have had their accounts actioned upon. That has been reported to be a 30 day suspension of their accounts.LinksProhibited Gameplay Incident and Response - General Discussion - World of Warcraft Forumshttps://x.com/jdotb/status/2080799736915775742S2 Date AnnouncedAugust 11th the patch goes live!New Outdoor Zone: The Coiled IsleNew Activities:Vaults of Atal'UtekPublic EventsCurse SurgesCursed FishingNew Eight-Boss Raid: The Venomous AbyssNew Three-Boss Dungeon: Altar of FangsNew Lairs for Normal, Heroic, and Mythic World Boss EncountersThree New Delves including a new Nemesis DelveMidnight Season 2 Begins August 18thMythic+ Dungeon UpdatesNew Players vs. Bots ArenaPrey Season 2New Arcantina QuestsUser Interface Updates for Cooldown Manager and Ping SystemHousing Updates:Save, Export, and Import BlueprintsWelcome Pets!Four New EndeavorsClass UpdatesLinksCurse of Ula'tek Goes Live August 11! Journey to the Coiled Isle.The Clock is Ticking on Midnight Season 1 Achievements and Rewards

Russia will extend its ban on gasoline exports through the end of 2026 to ensure stable domestic fuel supplies. Deputy Prime Minister Alexander Novak said the decision will apply to both gasoline producers and non-producers.

AI, Cybersecurity, and Public Policy: Export Controls, Arms Races, and the "New Radium" On Cyber Security Today (Weekend), the host interviews Pratim Datta, a Kent State University professor and former global consultant, about the past six months of AI and public policy as it intersects with cybersecurity. They discuss Anthropic's "Mythos" and "Fable," the marketing-versus-risk debate around autonomous hacking tools, and how the sheer volume of vulnerable code creates a "digitally polluted" environment. The conversation covers whether AI is a consumer product or a weapon, the implications of U.S. export controls (including restrictions affecting foreign nationals), and how model pullbacks may have shaken allies' trust in American tech. They also examine comparisons to radium and nuclear-era unknowns, the OpenAI–Hugging Face incident, the "cathedral vs. bazaar" tension of closed vs. open models, and the broader U.S.–China economic and national security struggle. 00:00 Weekend Show Kickoff 01:15 Meet Prat Dadam 01:59 Policy Whiplash in AI 02:55 Mythos Hype and Fear 06:27 Digital Pollution Problem 07:53 AI Arms Race Begins 09:18 Export Controls Shockwave 14:31 Weapon or Consumer Tech 16:57 New Radium Analogy 21:57 Economics and Trade Wars 23:49 Cathedral Versus Bazaar 25:44 Censorship and Control 27:16 Jurassic Park Chaos 30:27 Hotel California Reality 32:36 Closing Thoughts and Thanks

China is manufacturing solar panels at a scale that has transformed the economics of the global market. High-efficiency panels leaving China are currently priced at roughly eleven cents per watt. Some domestic Chinese prices are even lower.That sounds extraordinarily cheap. But the panel is only one component of a solar installation.The proper analysis begins with the building's hourly electrical load, not its annual utility bill.Two buildings can consume the same amount of electricity annually and have very different solar economics. A warehouse operating primarily during daylight hours may consume solar power as it is generated. An apartment building may experience its highest common-area loads during the evening, after solar production has declined.Electricity consumed directly inside the building is usually more valuable than electricity exported to the grid. Export compensation can be materially lower than the retail price, depending on the utility tariff.So, is a ten-year break-even compelling?Usually, not by itself.A ten-year payback represents an approximate unlevered return of ten percent before degradation, maintenance, equipment replacement and execution risk. It may still make sense for an owner with a long holding period, a newly replaced roof, strong tax benefits and confidence that the building will remain occupied.A five-year break-even is different. That implies roughly a twenty-percent simple return before considering residual value. For a durable system producing predictable savings, that can be highly attractive.------------**Real Estate Espresso Podcast:** Spotify: [The Real Estate Espresso Podcast](https://open.spotify.com/show/3GvtwRmTq4r3es8cbw8jW0?si=c75ea506a6694ef1)   iTunes: [The Real Estate Espresso Podcast](https://podcasts.apple.com/ca/podcast/the-real-estate-espresso-podcast/id1340482613)   Website: [www.victorjm.com](http://www.victorjm.com)   LinkedIn: [Victor Menasce](http://www.linkedin.com/in/vmenasce)   YouTube: [The Real Estate Espresso Podcast](http://www.youtube.com/@victorjmenasce6734)   Facebook: [www.facebook.com/realestateespresso](http://www.facebook.com/realestateespresso)   Email: [podcast@victorjm.com](mailto:podcast@victorjm.com)  **Y Street Capital:** Website: [www.ystreetcapital.com](http://www.ystreetcapital.com)   Facebook: [www.facebook.com/YStreetCapital](https://www.facebook.com/YStreetCapital)   Instagram: [@ystreetcapital](http://www.instagram.com/ystreetcapital)  

Could the wrong export distributor cost your MedTech business years of growth?Choosing an export distributor is one of the biggest commercial decisions a MedTech company will make. Yet many founders focus on impressive presentations instead of proven capability, give away exclusivity too early, or mistake a distributor for a complete go-to-market strategy. In this episode, Hakeem shares the five most common mistakes he sees and explains how to choose a distributor who becomes a genuine commercial partner.Listeners will discover:The five biggest mistakes MedTech companies make when selecting export distributorsHow to distinguish distributors with real capability from those who simply make a convincing sales pitchThe key questions every MedTech company should answer before signing a distributor agreementPlay this episode now to learn how to choose an export distributor who can accelerate adoption, support your commercial strategy, and help grow your MedTech business in international markets.If you want help with an underperforming distributor DM me on Linkedin saying "Distributor Support"This podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

- U.S. Could Ban Mercedes - GM Spends $11 Billion on EV Write-Offs - German Auto Exports to China Plummet - VW Prioritizes Group, Not Brands - VW Wants to Sell Stake in India Unit - Stellantis Turns to Mobileye for ADAS Tech - Stellantis Hires New Jeep and Ram CEOs - BMW Developing Robot Teaching Software

- U.S. Could Ban Mercedes - GM Spends $11 Billion on EV Write-Offs - German Auto Exports to China Plummet - VW Prioritizes Group, Not Brands - VW Wants to Sell Stake in India Unit - Stellantis Turns to Mobileye for ADAS Tech - Stellantis Hires New Jeep and Ram CEOs - BMW Developing Robot Teaching Software

Joe's Premium Subscription: www.standardgrain.comGrain Markets and Other Stuff Links —Apple PodcastsSpotifyTikTokYouTubeFutures and options trading involves risk of loss and is not suitable for everyone.

- DOJ Fain Probe May Extend UAW Federal Oversight - Honda Shrinks in China but Extends GAC Partnership - Honda Considers Building New North American Plant - China Auto Suppliers Pivot to Booming Motorcycle Sector - U.S. EV Sales Stabilize in May - Electric Cars Outsell All Other Powertrains in Germany - China Quietly Restricts Rare Earth Exports to U.S. - Struggling Aston Martin in Talks for New Liquidity

- DOJ Fain Probe May Extend UAW Federal Oversight - Honda Shrinks in China but Extends GAC Partnership - Honda Considers Building New North American Plant - China Auto Suppliers Pivot to Booming Motorcycle Sector - U.S. EV Sales Stabilize in May - Electric Cars Outsell All Other Powertrains in Germany - China Quietly Restricts Rare Earth Exports to U.S. - Struggling Aston Martin in Talks for New Liquidity

China's equipment manufacturing sector became a major driver of export growth in the first half of the year. The export delivery value of the equipment industry rose 18.2 percent and contributed about half of the growth in industrial exports.

Demand from key international markets helped lift the value of U.S. beef exports in May, even as shipment volumes declined.

***This episode is not edited as it was recorded directly after Donald Trump's speech***Donald Trump went on primetime television to tell the country that America's elections are compromised. A few hours earlier, Stephen Miller gave a much quieter speech at the State Department that was far more alarming. While Trump ranted about voter fraud, voting machines, China, mail ballots and election “security,” Miller laid out a federal counterterrorism strategy aimed directly at the political left.In this episode, Robin breaks down both speeches, what NSPM-7 actually does, and why the administration's plan for the 2026 midterms goes far beyond campaign messaging. The language is already in place: disrupt, identify, defund, debank, arrest and prosecute.Trump's address got the live blogs, cable coverage and instant fact-checks. He repeated unsupported claims about noncitizen voters, Chinese interference, stolen voter data and compromised election machines. He also announced plans to involve federal agencies in state election systems, remove people from voter rolls and investigate officials tied to the alleged fraud.But while everyone was watching Trump, Stephen Miller was explaining what comes next.Speaking to foreign security officials at a State Department ministerial, Miller described the political left as a terrorism threat and defended NSPM-7, a national security directive that gives federal agencies a broad mandate to target organizations, activists and financial networks.And the scope does not stop with people accused of violence. It can reach donors, organizers, lawyers, bail funds, nonprofits and anyone the administration decides is supporting the wrong movement.The speech also went somewhere even darker. Miller attacked civil liberties, complained about juries refusing to convict people accused of assaulting ICE agents, and told the room that leftists do not look “normal” because their appearance reflects what is supposedly inside them.That language is not random. Robin traces its historical roots and explains why authoritarian movements so often describe political opponents as diseased, deformed, dangerous or visibly different. Once the enemy is defined by who they are instead of what they have done, there is no way to behave your way out of the category.Trump provides the spectacle. Miller provides the machinery and framework for what's to come. Together, the two speeches point toward a broader strategy for the 2026 midterms:• Destroy confidence in election results before voting begins• Push federal agencies deeper into state election systems• Purge voter rolls in the name of election security• Threaten media outlets that refuse to cooperate• Treat protest networks and organizers as terrorism infrastructure• Intimidate donors, lawyers, nonprofits and bail funds• Use financial pressure and debanking without waiting for criminal convictions• Export the framework through international intelligence sharingThis episode separates what the administration has actually done from what it has merely claimed.The franework is real. The evidence being used to justify it often is not.Trump's speech was the distraction. Stephen Miller's speech was the blueprint.The loud speech told America what to fear. The quiet speech explained what the government plans to do about it.Topics include Donald Trump, Stephen Miller, NSPM-7, the 2026 midterm elections, voter purges, election security, left-wing terrorism, debanking, civil liberties, ICE protests, jury trials, political repression, authoritarianism, fascism, voter fraud claims, media license threats and federal intervention in state elections.Become a supporter of this podcast: https://www.spreaker.com/podcast/we-saw-the-devil-unfiltered-political-analysis--4433638/support.Website: http://www.wesawthedevil.comPatreon: http://www.patreon.com/wesawthedevilRobin's Instagram: http://www.instagram.com/robin_wstdTwitter: http://www.twitter.com/WeSawtheDevilInstagram: http://www.instagram.com/wesawthedevilpodcast.TikTok: tiktok.com/@wesawthedevilpolitics

Joe's Premium Subscription: www.standardgrain.comGrain Markets and Other Stuff Links —Apple PodcastsSpotifyTikTokYouTubeFutures and options trading involves risk of loss and is not suitable for everyone.

Russia's Energy Chokepoint and the Shifting Global Oil Map. Michael Bernstam. Ukrainian drone strikes on major Russian refineries have triggered a severe fuel crisis, forcing export bans on diesel and gasoline. Meanwhile, Gulf states are building massive pipelines to bypass the Strait of Hormuz. These developments are neutralizing Iran's "golden weapon" and shifting global oil transit maps away from traditional naval chokepoints. (9)

Regulation gets you approved. A go-to-market strategy gets you adopted.The question is: are you spending more time preparing your medical device for approval than preparing it for commercial success?Many clinician founders believe launching a medical device starts with regulation, manufacturing, or raising investment. But by the time you're thinking about those things, many of the decisions that determine commercial success have already been made. In this episode, Hakeem shares a practical seven-step framework to help you validate the problem, build the right evidence, develop a go-to-market strategy, and create the foundations for successful commercialisation and future expansion into export markets.Listeners will discover:The seven stages every clinician should complete before commercialising and exporting a medical deviceWhy validating the problem, evidence, and go-to-market strategy matters more than rushing to launchHow to identify the biggest commercial constraint holding your MedTech business back and prioritise the next step towards adoption, sales, and international growthPlay this episode now to benchmark your progress against the seven-step framework and discover the next step that will help you commercialise, export, and grow your medical device business with confidence.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Mac Geek Gab 1148 hands you a fresh stack of Quick Tips you’ll actually use. You’ll find out how Mark recovered every one of his accidentally deleted iMessages with Control-Command-4 (or the Recently Deleted view), undo a botched Finder rename with a casual Command-Z, and automate Theater Mode on your Apple Watch so it goes dim and quiet at night without Sleep Focus. You’ll pick up several ways to email a Safari webpage or just its link, learn to strip out distracting page clutter before you share, and finally understand why Apple Music can hijack your Mac’s default speaker output. Then you’ll hear why speakers deserve real thought before you buy a Mac mini, how to coax a stubborn Time Machine disk into ejecting cleanly, and a low-tech trick for AirTags too slippery to grip at battery-change time. When Doug’s M4 Pro MacBook Pro started beach balling and pausing apps from low memory, you’ll get the full playbook for clawing back storage, from spotting the culprits in your menu bar to pruning Downloads and clearing out bloated Messages and Apple media. You’ll walk through Adam’s step-by-step approach to slimming down iMessage storage, learn how to stop copying and pasting invisible white-on-white text that haunts Contacts and email, and speed up a sluggish macOS Contacts app with a clean iCloud re-sync. Keep these moves in your back pocket and don’t get caught with a full drive and a spinning beach ball. 00:00:00 Mac Geek Gab 1148 for Monday, June 29th, 2026 June 29th: National Bacon Burnt End Day MGG Monthly Giveaway – Win a license to SaneBox Quick Tips 00:00:01 Mark-QT-You can recover recently deleted iMessages ^Cmd-4 (not 5) 00:03:45 Scott-QT-Cmd-Z works to undo Finder Renames, too! 00:05:06 Larry-QT-Automate Theater Mode on Apple Watch 00:06:36 Hans-QT-Email a Safari Webpage to Someone 00:08:17 Russ-QT-Apple Music can override the Mac’s default speaker output Volumio 00:11:42 Adam-QT-More on Cmd-I (and Cmd-Shift-I) in Safari to mail a webpage (or the link) Likely based upon the web page's print.css Also File – Export as PDF 00:17:39 Safari – Hide Distracting Items The (no-longer-actively-developed) Printliminator 00:21:33 Doug-QT-Think about speakers when buying a Mac mini Insta360 Link 2 Pro 00:28:02 Bill-QT-Try Jettison, Mole, and more to eject resistant volumes 00:30:36 Dom-QT-Use tape or thimbles for slippery AirTags Sponsors 00:32:06 SPONSOR: Coveron. One scam can cost you everything. Tools reduce risk, Coveron reduces loss. Use code “macgeekgab” for up to 76% off at https://coveron.com/macgeekgab 00:33:55 SPONSOR: OneSkin. Born from over a decade of longevity research, OneSkin's OS-01 Peptide is proven to target the visible signs of aging, helping you unlock your healthiest skin now and as you age. Get 15% off OneSkin with the code MGG at https://www.oneskin.co/MGG  #oneskinpod #ad 00:35:22 SPONSOR: BBEdit, the power tool for text from Bare Bones Software; now with integrated Notebooks and extended language support. Your Questions Answered and Tips Shared! 00:36:49 Doug-Beach balling apps made me realize I ran out of storage…what do I do? iStat Menus to see free disk space in my menubar How to free up space on your Mac Run mole…regularly! Hazel to keep your downloads folder pruned Run CleanMyMac – Space Lens, especially Clear out your Apple media Manage your Email attachments Clean out Messages CCleaner Clean up local snapshots 00:50:51 Adam's process for cleaning up iMessage storage use 00:56:21 Steven-How can I avoid pasting white text on a white background on my iPhone? 01:02:55 Mark-Speed up macOS Contacts with an iCloud re-sync ~/Library/Application Support/AddressBook/Sources//AddressBook-v22.abcddb Cool Stuff Found 01:13:18 Adam-CSF-Dungeon Crawler Carl 01:18:36 MGG 1148 Outtro MGG Monthly Giveaway Bandwidth Provided by CacheFly Pilot Pete's Aviation Podcast: So There I Was (for Aviation Enthusiasts) The Debut Film Podcast – Adam's new podcast! Dave's Business Brain (for Entrepreneurs) and Gig Gab (for Working Musicians) Podcasts MGG Merch is Available! Mac Geek Gab iOS app Mac Geek Gab YouTube Page Mac Geek Gab Live Calendar This Week's MGG Premium Contributors MGG Apple Podcasts Reviews feedback@macgeekgab.com 224-888-GEEK Active MGG Sponsors and Coupon Codes List BackBeat Media Podcast Network